BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6154061)

  • 1. Cytoplasmic and nuclear androgen receptor content of normal and neoplastic human prostates and lymph node metastases of human prostatic adenocarcinoma.
    Shain SA; Boesel RW; Lamm DL; Radwin HM
    J Clin Endocrinol Metab; 1980 Apr; 50(4):704-11. PubMed ID: 6154061
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgen receptor content of normal and hyperplastic human prostate.
    Trachtenberg J; Bujnovszky P; Walsh PC
    J Clin Endocrinol Metab; 1982 Jan; 54(1):17-21. PubMed ID: 6172440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histochemical detection of steroid hormone receptors in the human prostate.
    Pertschuk LP; Zava DT; Tobin EH; Brigati DJ; Gaetjens E; Macchia RJ; Wise GJ; Wax HS; Kim DS
    Prog Clin Biol Res; 1979; 33():113-32. PubMed ID: 93748
    [No Abstract]   [Full Text] [Related]  

  • 4. Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Shimazaki J; Hikage T; Sato R; Kodama T; Ito H
    Endocrinol Jpn; 1981 Dec; 28(6):725-34. PubMed ID: 6179768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Androgen receptors in cytosol in benign prostatic hyperplasia].
    Corrales Hernandez JJ; Miralles Garcia JM; Montero Gomez J; Martin T; Martin Rodriguez M; Gonzalez Buitrago JM
    Rev Clin Esp; 1983 Feb; 168(4):233-7. PubMed ID: 6190202
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.
    Rowley DR; Thompson SA; Lubaroff DM; Heidger PM
    Prostate; 1984; 5(1):101-11. PubMed ID: 6607463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor binding activity in human prostate cancer.
    Benson RC; Utz DC; Holicky E; Veneziale CM
    Cancer; 1985 Jan; 55(2):382-8. PubMed ID: 2578085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic and nuclear androgen receptors of human prostate.
    Shain SA; Boesel RW; Radwin HM; Lamm DL
    Prog Clin Biol Res; 1979; 33():33-49. PubMed ID: 93751
    [No Abstract]   [Full Text] [Related]  

  • 10. Nuclear androgen receptors in prostates from diabetic rats.
    Tesone M; Oliveira-Filho RM; Valle LB; Barañao JL; Foglia VG; Charreau EH
    Horm Metab Res; 1982 May; 14(5):237-40. PubMed ID: 7047345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and measurement of androgen receptors in human prostatic tissue.
    Walsh PC; Hicks LL
    Prog Clin Biol Res; 1979; 33():51-63. PubMed ID: 531047
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased levels of nuclear androgen receptors in hyperplastic prostate of aging men.
    Grimaldo JI; Meikle AW
    J Steroid Biochem; 1984 Aug; 21(2):147-50. PubMed ID: 6207385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen binding sites on nuclear matrix of normal and hyperplastic human prostate.
    Donnelly BJ; Lakey WH; McBlain WA
    J Urol; 1984 Apr; 131(4):806-11. PubMed ID: 6200614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
    Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: can estrogen treatment increase androgen receptor content?
    Mobbs BG; Johnson IE; Connolly JG; Thompson J
    J Steroid Biochem; 1983 Sep; 19(3):1279-90. PubMed ID: 6604842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of androgen receptor in human prostatic tissues and demonstration of decreased androgen receptor content in metastatic prostate cancer.
    Kliman B; Prout GR; MacLaughlin RA
    Surg Forum; 1979; 30():550-1. PubMed ID: 94190
    [No Abstract]   [Full Text] [Related]  

  • 18. Human prostate androgen receptor quantitation: effects of temperature on assay parameters.
    Shain SA; Gorelic LS; Boesel RW; Radwin HM; Lamm DL
    Cancer Res; 1982 Nov; 42(11):4849-54. PubMed ID: 6982098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.
    Carilla E; Briley M; Fauran F; Sultan C; Duvilliers C
    J Steroid Biochem; 1984 Jan; 20(1):521-3. PubMed ID: 6200701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881.
    Akimoto S; Fuse H; Sato R; Zama S; Shimazaki J
    Endocrinol Jpn; 1985 Feb; 32(1):141-52. PubMed ID: 2410244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.